Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Editorial Boards
    • Contact Us
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Editorial Boards
    • Contact Us
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Resident & Fellow Section

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
American Academy of Neurology Journals
Home
  • Subscribe
  • My Alerts
  • Log in
Site Logo

Glycogenoses

Latest Articles

  • Research Article
    Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
    Mazen M. Dimachkie, Richard J. Barohn, Barry Byrne, et al.
    Neurology May 26, 2022
  • Article
    Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic PracticesThe IPaNeMA Study
    Marie Wencel, Aziz Shaibani, Namita A. Goyal, et al.
    Neurology Genetics October 18, 2021
  • Article
    Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease
    Laurike Harlaar, Jean-Yves Hogrel, Barbara Perniconi, et al.
    Neurology October 16, 2019
  • Article
    Clinical heterogeneity and phenotype/genotype findings in 5 families with GYG1 deficiency
    Rabah Ben Yaou, Aurélie Hubert, Isabelle Nelson, et al.
    Neurology Genetics December 18, 2017
Show more
Advertisement
  • Neurology Podcast - Over 16 million downloads!
    Young-Onset Ischemic Stroke Risk Factors in Black and White Individuals
    Dr. B.J. Hicks talks with Dr. Prachi Mehndiratta about the differences in multiple risk factors between Black and White individuals with young-onset ischemic stroke.
    August 11, 2022
    Neurology, Journal, Podcast
    Listen11:01
    Subscribe
    View Recent Podcasts
Site Logo
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise